MEDTOX Scientific, of St Paul, Minneapolis, has gained US FDA 510(k) clearance to market its rapid test for the qualitative detection of two drugs-of-abuse, ecstasy (methylenedioxymethamphetamine) and methamphetamine. The Verdict-II test is a one-step, immunochromatographic test that detects the drugs in urine.
FDA clears MEDTOX' drugs-of-abuse test :
MEDTOX Scientific, of St Paul, Minneapolis, has gained US FDA 510(k) clearance to market its rapid test for the qualitative detection of two drugs-of-abuse, ecstasy (methylenedioxymethamphetamine) and methamphetamine. The Verdict-II test is a one-step, immunochromatographic test that detects the drugs in urine.